Ruitao Lin

From MaRDI portal
(Redirected from Person:512443)
Ruitao Lin Q512443



List of research outcomes

This list is not complete and representing at the moment only items from zbMATH Open and arXiv. We are working on additional sources - please check back here soon!

PublicationDate of PublicationType
An integrated test on the linear structure of high-dimensional covariance matrices
Random Matrices: Theory and Applications
2026-03-05Paper
Bayesian integrated learning of longitudinal dose-response relationships via decentralized clinical trials
Statistics in Medicine
2026-02-18Paper
DEMO: dose exploration, monitoring, and optimization using biological and clinical outcomes
The Annals of Applied Statistics
2026-01-12Paper
COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapies
Biometrics
2025-11-06Paper
TODO: a triple-outcome double-criterion optimal design for dose monitoring-and-optimization in multi-dose randomized trials
Statistics in Medicine
2025-11-01Paper
Comments on: ``Competing designs for drug combination in phase I dose-finding clinical trials
Statistics in Medicine
2025-10-09Paper
Non-parametric overdose control for dose finding in drug combination trials
Journal of the Royal Statistical Society. Series C. Applied Statistics
2024-11-21Paper
TITE-BOIN12: a Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy
Statistics in Medicine
2024-10-29Paper
Online bootstrap inference for the geometric median
Computational Statistics and Data Analysis
2024-10-29Paper
uTPI: a utility-based toxicity probability interval design for phase I/II dose-finding trials
Statistics in Medicine
2024-10-29Paper
BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints
Statistics in Medicine
2024-10-29Paper
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints
Biometrical Journal
2024-10-28Paper
Comparative review of novel model-assisted designs for phase I/II clinical trials
Biometrical Journal
2024-10-28Paper
REDOMA: Bayesian random-effects dose-optimization meta-analysis using spike-and-slab priors
Statistics in Medicine
2024-10-14Paper
Design and sample size determination for multiple-dose randomized phase II trials for dose optimization
Statistics in Medicine
2024-10-08Paper
On singular values of large dimensional lag-\(\tau\) sample auto-correlation matrices
Journal of Multivariate Analysis
2023-08-08Paper
Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials
The Annals of Applied Statistics
2022-10-10Paper
A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes
Bayesian Analysis
2021-12-06Paper
BAGS: a Bayesian adaptive group sequential trial design with subgroup-specific survival comparisons
Journal of the American Statistical Association
2021-03-30Paper
Two-sample tests for high-dimensional covariance matrices using both difference and ratio
Electronic Journal of Statistics
2021-01-19Paper
An adaptive trial design to optimize dose-schedule regimes with delayed outcomes
Biometrics
2020-10-26Paper
Testing homogeneity of high-dimensional covariance matrices
STATISTICA SINICA
2020-03-16Paper
Power computation for hypothesis testing with high-dimensional covariance matrices
Computational Statistics and Data Analysis
2018-08-15Paper
Bootstrap aggregating continual reassessment method for dose finding in drug-combination trials
The Annals of Applied Statistics
2017-02-24Paper


Research outcomes over time


This page was built for person: Ruitao Lin